PA8627401A1 - Composiciones diuréticas de liberación prolongada - Google Patents

Composiciones diuréticas de liberación prolongada

Info

Publication number
PA8627401A1
PA8627401A1 PA20058627401A PA8627401A PA8627401A1 PA 8627401 A1 PA8627401 A1 PA 8627401A1 PA 20058627401 A PA20058627401 A PA 20058627401A PA 8627401 A PA8627401 A PA 8627401A PA 8627401 A1 PA8627401 A1 PA 8627401A1
Authority
PA
Panama
Prior art keywords
prolonged release
compositions
diuretic
diuretic compositions
release
Prior art date
Application number
PA20058627401A
Other languages
English (en)
Inventor
Alfonso Romero
Marta Guerrero
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34962072&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PA8627401(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of PA8627401A1 publication Critical patent/PA8627401A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSICIONES DIURETICAS DE LIBERACION PROLONGADA QUE COMPRENDEN EL PRINCIPIO ACTIVO TORASEMIDA, LAS CUALES SUPONEN UNA GRAN VENTAJA AL EVITAR LAS MOLESTAS URGENCIAS URINARIAS CAUSADAS POR LAS COMPOSICIONES CONVENCIONALES DE LIBERACION INMEDIATA.
PA20058627401A 2004-03-25 2005-03-24 Composiciones diuréticas de liberación prolongada PA8627401A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200400740A ES2244324B1 (es) 2004-03-25 2004-03-25 Composiciones diureticas de liberacion prolongada.

Publications (1)

Publication Number Publication Date
PA8627401A1 true PA8627401A1 (es) 2005-11-25

Family

ID=34962072

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20058627401A PA8627401A1 (es) 2004-03-25 2005-03-24 Composiciones diuréticas de liberación prolongada

Country Status (20)

Country Link
US (1) US20080187585A1 (es)
EP (1) EP1732517B1 (es)
JP (1) JP4871258B2 (es)
KR (1) KR101203763B1 (es)
CN (1) CN1946379B (es)
AR (1) AR048432A1 (es)
AU (1) AU2005227095B2 (es)
BR (1) BRPI0509165A (es)
CA (1) CA2562142C (es)
ES (2) ES2244324B1 (es)
MX (1) MXPA06010833A (es)
NO (1) NO336582B1 (es)
PA (1) PA8627401A1 (es)
PE (1) PE20060015A1 (es)
PL (1) PL1732517T3 (es)
PT (1) PT1732517T (es)
RU (2) RU2006137671A (es)
TW (1) TWI351957B (es)
UY (1) UY28809A1 (es)
WO (1) WO2005092291A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10596119B1 (en) * 2018-11-08 2020-03-24 Sarfez Pharmaceuticals, Inc. Methods of treatment comprising torsemide
US10463622B2 (en) * 2013-10-06 2019-11-05 Sarfez Pharmaceuticals, Inc. Treatments and formulations comprising Torsemide
EP3065718A4 (en) * 2013-10-06 2017-07-12 Sarfez Pharmaceuticals, Inc. Controlled-release formulations comprising torsemide
EP3031471A1 (en) * 2014-12-12 2016-06-15 Ceva Sante Animale Veterinary composition for the treatment of pulmonary edema associated with heart failure in domestic animals

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3305935C2 (de) * 1983-02-21 1985-05-30 Medice Chem.-Pharm. Fabrik Pütter GmbH & Co KG, 5860 Iserlohn Kaliumneutrales Saluretikum mit antihypertensiver Wirkung
DE3529529A1 (de) * 1985-08-17 1987-02-19 Boehringer Mannheim Gmbh Verfahren zur herstellung einer stabilen modifikation von torasemid
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
JP3586471B2 (ja) * 1991-06-25 2004-11-10 三菱ウェルファーマ株式会社 トラセミド含有医薬組成物
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
GB9816899D0 (en) * 1998-08-05 1998-09-30 Boots Co Plc Therapeutic agents
CA2379322A1 (en) * 1999-08-11 2001-02-15 Teva Pharmaceutical Industries Ltd. Torsemide polymorphs
SK11632003A3 (sk) * 2000-02-17 2004-04-06 Teva Pharmaceutical Industries Ltd. Stabilný farmaceutický prípravok obsahujúci modifikáciu II torsemidu
DE10013289A1 (de) * 2000-03-17 2001-09-20 Knoll Ag Torasemid enthaltende pharmazeutische Zubereitungen
US20030119882A1 (en) * 2001-10-22 2003-06-26 Markus Maegerlein Solid pharmaceutical composition containing torasemide
US20030152622A1 (en) * 2001-10-25 2003-08-14 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral diuretic
US20030104052A1 (en) * 2001-10-25 2003-06-05 Bret Berner Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
US6863901B2 (en) * 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
HRP20020124A2 (en) * 2002-02-11 2003-10-31 Pliva D D Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
AU2004299077A1 (en) * 2003-12-12 2005-06-30 Penwest Pharmaceuticals Co. Sustained release torsemide dosage forms

Also Published As

Publication number Publication date
PE20060015A1 (es) 2006-02-02
EP1732517B1 (en) 2017-05-03
PL1732517T3 (pl) 2017-09-29
CN1946379B (zh) 2012-05-16
NO336582B1 (no) 2015-09-28
KR101203763B1 (ko) 2012-11-23
AU2005227095B2 (en) 2010-10-28
CA2562142A1 (en) 2005-10-06
CN1946379A (zh) 2007-04-11
ES2244324A1 (es) 2005-12-01
ES2244324B1 (es) 2006-11-16
UY28809A1 (es) 2005-07-29
TW200531693A (en) 2005-10-01
PT1732517T (pt) 2017-08-03
MXPA06010833A (es) 2006-12-15
RU2006137671A (ru) 2008-04-27
CA2562142C (en) 2012-06-05
WO2005092291A1 (en) 2005-10-06
TWI351957B (en) 2011-11-11
AU2005227095A1 (en) 2005-10-06
RU2449778C1 (ru) 2012-05-10
NO20064834L (no) 2006-12-07
ES2632354T3 (es) 2017-09-12
US20080187585A1 (en) 2008-08-07
EP1732517A1 (en) 2006-12-20
JP4871258B2 (ja) 2012-02-08
BRPI0509165A (pt) 2007-09-11
JP2007530510A (ja) 2007-11-01
KR20060130756A (ko) 2006-12-19
AR048432A1 (es) 2006-04-26

Similar Documents

Publication Publication Date Title
DK1902037T3 (da) 2,4-diamino-pyrimidiner som auroainhibitorer
TW200613500A (en) Michael addition compositions
NO20071000L (no) Antimikrobielle sølvsammensetninger.
DE602005019354D1 (de) Brecherbefestigungsvorrichtung.
NL2000373A1 (nl) Antibacteriele middelen.
DE602005002227D1 (de) Spam-Abwehr durch Überprüfung von Zwischennetzwerk-Nachrichten
CR7970S (es) Botella
ES1061121Y (es) Carton biodegradable.
FR2882610B1 (fr) Disjoncteur.
JP2008050558A5 (es)
TW200613003A (en) Active compound-containing solid moulded bodies for external use against parasites on animals
CY1109209T1 (el) Μητρες ανιονικης υδρογελης με ph-εξαρτωμενη τροποιημενη αποδεσμευση ως μεταφορεις φαρμακων
GT200600121A (es) Novedosos derivados de triazolopirimidina
CR7758S (es) Barra de caramelo (paloma)
UA100850C2 (ru) Средство для борьбы с паразитами на животных
PA8627401A1 (es) Composiciones diuréticas de liberación prolongada
NL1031384A1 (nl) Gesubstitueerde aryl-1,4-pyrazinederivaten.
CR8619A (es) Agentes parasiticidas
NL1029686A1 (nl) Oxazolidinonen die oxindolen bevatten als antibacteriele middelen.
ATE538121T1 (de) 1,5,6-substituierte-2-oxo-3-cyano-1,6a- diazatetrahydrofluoranthene als antiinfektionsmittel
ITMI20051746A1 (it) Macchina i.s.
NL1031525A1 (nl) 7-Fluor-1,3-dihydroindool-2-onoxazolidinonen als antibacteriele middelen.
AR053804A1 (es) Composicion para controlar parasitos
DE602004018483D1 (de) Fotopolymerisierbare Zusammensetzung.
ES1053041Y (es) Bateria auto-desconectable por colision.